# L-Theanine in the Management of Schizophrenia

> **NCT00372151** · PHASE3 · COMPLETED · sponsor: **Sha'ar Menashe Mental Health Center** · enrollment: 60 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DIETARY_SUPPLEMENT:** L-Theanine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00372151
- **Lead sponsor:** Sha'ar Menashe Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2008-12-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00372151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00372151, "L-Theanine in the Management of Schizophrenia". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00372151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*